Minocycline attenuates the development of diabetic neuropathy by modulating DREAM and BDNF protein expression in rat spinal cord.
Che Aishah Nazariah IsmailRapeah SuppianChe Badariah Abd AzizIdris LongPublished in: Journal of diabetes and metabolic disorders (2019)
This study revealed that minocycline could attenuate DNP by modulating spinal BDNF and DREAM protein expressions.